Pay in 4 interest-free payments of $13.75 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
936091-26-8
Inhibition of cathepsin L thus holds promise for therapeutic intervention for both SARS-CoV and Ebola virus infection
Journal of Medicinal Chemistry (2020)
but can also induce the regression of pre-existing fibrosis
Epub 2013 Feb 1
Valrubicin - CAS# 56124-62-0 123 936091-26-8Valrubicin, CAS No. 56124 62 0, is a semisynthetic derivative of the antineoplastic anthracycline antibiotic doxorubicin. With a mechanism of action that appears to differ from doxorubicin, valrubicin is converted intracytoplasmically into N trifluoroacetyladriamycin, which interacts with topoisomerase II, stabilizing the complex between the enzyme and DNA; consequently, DNA replication and repair and RNA and protein synthesis are inhibited and the